PCVX
Published on 05/08/2025 at 03:15, updated on 05/13/2025 at 13:20
Presenter SpeechJason Gerberry (Analysts)
First off, my name is Jason Gerberry. I'm one of the mid-cap biotech analysts at BofA. I'm pleased to be introducing Vaxcyte's Andrew Guggenhime, Chief
S